Key result
This protocol outlines a planned scoping review to summarize the indications, agents used, and outcomes assessed regarding vasoactive agents in patients undergoing non-cardiac surgery.
Why the study?
Perioperative hypotension is associated with adverse outcomes, but whether one vasoactive agent is preferable over another has yet to be explored.
What are the indications, agents used, and outcomes assessed for vasoactive agents in patients undergoing non-cardiac surgery?
What are the indications, agents used, and outcomes assessed for vasoactive agents in patients undergoing non-cardiac surgery?
This protocol outlines a planned scoping review to map the evidence on the use of vasoactive agents for perioperative hypotension in non-cardiac surgery.
Variability across studies precludes preferring one vasoactive agent for perioperative hypotension; leaves open need for standardized comparative trials.
BACKGROUND: An increasing number of patients undergo surgical procedures worldwide each year, and despite advances in quality and care, morbidity and mortality rates remain high. Perioperative hypotension is a well-described condition, and is associated with adverse outcomes. Both fluids and vasoactive agents are commonly used to treat hypotension, however, whether one vasoactive agent is preferable over another has yet to be explored. METHODS: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) statement, we plan to conduct a scoping review of studies assessing the use of vasoactive agents in patients undergoing non-cardiac surgery. We will provide an overview of indications, agents used and outcomes assessed. We will assess and report the certainty of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. RESULTS: We will provide descriptive analyses of the included studies accompanied by tabulated results. CONCLUSION: The outlined scoping review will provide a summary of the body of evidence on the use of vasoactive agents in the non-cardiac surgical population.
No takes yet. Share an insight, caveat, or question.
Bækgaard et al. (2022) conducted a review in Perioperative hypotension in non-cardiac surgery. Vasoactive agents was evaluated. This protocol outlines a planned scoping review to summarize the indications, agents used, and outcomes assessed regarding vasoactive agents in patients undergoing non-cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: